Literature DB >> 29895544

Osteoporosis and malignancy: a dicey combination.

Nandhini Lakshmana Perumal1, Jayakumar Selvi1, Jaya Prakash Sahoo1, Sadishkumar Kamalanathan1.   

Abstract

Osteoporosis is the most common metabolic bone disorder worldwide, especially in women. Postmenopausal status is the most common risk factor for osteoporosis in elderly women. The operational diagnosis of osteoporosis is usually made with the help of central dual energy X-ray absorptiometry scan. Clinically, osteoporosis is suspected in the background of one or more fractures of the hip, vertebra, proximal humerus or pelvis in the absence of local disease or high-energy trauma. Serious underlying illness can present with vertebral fractures and can be missed if other clues from clinical examination and investigations are overlooked. We report a case emphasising this aspect. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  calcium and bone; lung cancer (oncology)

Mesh:

Substances:

Year:  2018        PMID: 29895544      PMCID: PMC6011445          DOI: 10.1136/bcr-2017-223881

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

Review 1.  Management of acute hypercalcemia.

Authors:  J P Bilezikian
Journal:  N Engl J Med       Date:  1992-04-30       Impact factor: 91.245

2.  Hypercalcemia and ectopic secretion of parathyroid hormone by an ovarian carcinoma with rearrangement of the gene for parathyroid hormone.

Authors:  S R Nussbaum; R D Gaz; A Arnold
Journal:  N Engl J Med       Date:  1990-11-08       Impact factor: 91.245

Review 3.  Clinical practice. Hypercalcemia associated with cancer.

Authors:  Andrew F Stewart
Journal:  N Engl J Med       Date:  2005-01-27       Impact factor: 91.245

Review 4.  Onco-nephrology: the pathophysiology and treatment of malignancy-associated hypercalcemia.

Authors:  Mitchell H Rosner; Alan C Dalkin
Journal:  Clin J Am Soc Nephrol       Date:  2012-08-09       Impact factor: 8.237

5.  The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism.

Authors:  Scott M Wilhelm; Tracy S Wang; Daniel T Ruan; James A Lee; Sylvia L Asa; Quan-Yang Duh; Gerard M Doherty; Miguel F Herrera; Janice L Pasieka; Nancy D Perrier; Shonni J Silverberg; Carmen C Solórzano; Cord Sturgeon; Mitchell E Tublin; Robert Udelsman; Sally E Carty
Journal:  JAMA Surg       Date:  2016-10-01       Impact factor: 14.766

6.  Studies of the hypercalcaemia of sarcoidosis: effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25-dihydroxy vitamin D3.

Authors:  L M Sandler; C G Winearls; L J Fraher; T L Clemens; R Smith; J L O'Riordan
Journal:  Q J Med       Date:  1984

Review 7.  Clinical review: Parathyroid localization and implications for clinical management.

Authors:  John W Kunstman; Jonathan D Kirsch; Amit Mahajan; Robert Udelsman
Journal:  J Clin Endocrinol Metab       Date:  2013-01-23       Impact factor: 5.958

Review 8.  A practical approach to hypercalcemia.

Authors:  Mary F Carroll; David S Schade
Journal:  Am Fam Physician       Date:  2003-05-01       Impact factor: 3.292

9.  Denosumab for treatment of hypercalcemia of malignancy.

Authors:  Mimi I Hu; Ilya G Glezerman; Sophie Leboulleux; Karl Insogna; Rasim Gucalp; Waldemar Misiorowski; Bennett Yu; Paul Zorsky; Diego Tosi; Alberto Bessudo; Arnaud Jaccard; Giuseppe Tonini; Wendy Ying; Ada Braun; Rajul K Jain
Journal:  J Clin Endocrinol Metab       Date:  2014-06-10       Impact factor: 5.958

Review 10.  Bone Metastases: An Overview.

Authors:  Filipa Macedo; Katia Ladeira; Filipa Pinho; Nadine Saraiva; Nuno Bonito; Luisa Pinto; Francisco Goncalves
Journal:  Oncol Rev       Date:  2017-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.